Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect
Jiyun Lee, Binnari Kim, Hyun Ae Jung, Yoon‐La Choi, Jong‐Mu Sun
Topics & Concepts
NivolumabMedicineInternal medicineCD8Confidence intervalEsophageal squamous cell carcinomaGastroenterologyRefractory (planetary science)OncologyCarcinomaImmunotherapyImmune systemImmunologyCancerAstrobiologyPhysicsCancer Immunotherapy and BiomarkersEsophageal Cancer Research and TreatmentImmunotherapy and Immune Responses